United States Diagnostics & Research news

14:30 4 Aug 2026

01net Earnings Main company 🇺🇸 United States

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories reported strong second quarter 2026 results, with revenue growth of 10% and EPS increasing by 18%. The company's Companion Animal Group Diagnostics recurring revenue grew by 11%, driven by innovation and increased diagnostic utilization. IDEXX also narrowed its 2026 revenue guidance and …

IDXX main company

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

14:15 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?

NeoGenomics, Inc. (NEO) recently hit a new 52-week high, with its stock up 4.5% in the past month and 34.7% since the start of the year. This outperformance is attributed to strong earnings surprises, with expected EPS growth of 50% for the current fiscal …

NEO main company

Sharemaestro market context Trend signal active 52 weeks +141.3% · Next-week setup negative 40.8%

13:40 4 Aug 2026

Bitget Earnings Main company 🇺🇸 United States

Insight Molecular Diagnostics updates financial calendar ahead of quarterly results webinar

Insight Molecular Diagnostics announced updates to its financial calendar, scheduling its Q2 2026 results webinar for August 10, 2026, at 5 p.m. ET. Additionally, management will participate in the Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026. This news brief was …

IMDX main company

Sharemaestro market context Price below Trend Line 52 weeks +66.8%

13:38 4 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Mettler-Toledo International (NYSE:MTD) Given New $1,450.00 Price Target at Morgan Stanley

Morgan Stanley has raised its price target for Mettler-Toledo International (NYSE:MTD) to $1,450.00 from $1,275.00, while maintaining an "equal weight" rating. This adjustment follows Mettler-Toledo's strong second-quarter earnings, where it surpassed EPS estimates with $11.46 and saw revenue grow by 4.5% year-over-year to $1.03 …

MTD main company

Sharemaestro market context Price above Trend Line 52 weeks +7.4% · Next-week setup positive 57.4%

13:23 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Revvity Tops Second-Quarter Estimates and Lifts Full-Year Outlook

Revvity, Inc. (NYSE:RVTY) reported strong second-quarter 2026 results, surpassing analyst expectations for both earnings and revenue. This performance led the health sciences company to raise its full-year guidance, with increased investments planned due to tariff refunds. The Diagnostics division was a key growth driver, …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

13:20 4 Aug 2026

Quiver Quantitative Earnings Main company 🇺🇸 United States

Exagen Reports Record Second-Quarter Revenue and Narrows Losses, Raises Full-Year 2026 Guidance

Exagen (XGN) announced record second-quarter 2026 revenue of $19.9 million, a 16% increase year-over-year. Despite a net loss of $3.2 million, the company raised its full-year 2026 revenue guidance to $72 million to $75 million. Insider trading data shows recent sales by executives, while …

XGN main company

Sharemaestro market context Trend signal active 52 weeks -34.1%

12:48 4 Aug 2026

AlphaStreet Earnings Main company 🇺🇸 United States

Revvity Releases Q2 2026 Financial Results

Revvity, Inc. reported strong Q2 2026 financial results, exceeding Wall Street's EPS estimates by 12.8% with adjusted EPS of $1.41 and revenue of $729.7M. The Diagnostics segment led growth, and the company raised its full-year 2026 guidance for adjusted EPS and revenue, reflecting confidence …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

12:48 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimates

Revvity (RVTY) reported strong Q2 results, with earnings of $1.41 per share and revenues of $729.69 million, both exceeding Zacks Consensus Estimates. The company has consistently surpassed EPS estimates over the last four quarters, and its stock has gained 19.1% year-to-date. Revvity currently holds …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

12:41 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Exagen Inc. Reports Second Quarter 2026 Financial Results

Exagen Inc. (Nasdaq: XGN) reported record total revenue of $19.9 million for the second quarter of 2026, a 16% increase year-over-year, and narrowed its adjusted EBITDA loss to $0.1 million. The company achieved a trailing twelve-month average selling price (ASP) of $446 for its …

XGN main company

Sharemaestro market context Trend signal active 52 weeks -34.1%

12:39 4 Aug 2026

Stock Titan Market update Main company 🇺🇸 United States

Twist Bioscience's 24 New Hires Set to Receive Stock Awards

Twist Bioscience (NASDAQ: TWST) announced it will grant a total of 44,434 restricted stock units (RSUs) to 24 new employees as an inducement to employment. These grants are made under the company's Amended and Restated Inducement Equity Incentive Plan, in compliance with Nasdaq Listing …

TWST main company

Sharemaestro market context Trend signal active 52 weeks +314.7%

12:38 4 Aug 2026

Hackread Market update Main company 🇺🇸 United States

Thermo Fisher Patches Forensic DNA File Tampering Flaw in Its Software

Thermo Fisher Scientific has released security updates for several of its Applied Biosystems human identification products to address a critical vulnerability (CVE-2026-17583) that allowed undetectable tampering of forensic DNA data files. The updates introduce digital signatures to help laboratories verify file integrity. However, older, …

TMO main company

Sharemaestro market context Trend signal started 52 weeks +18.1%

12:37 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates

Idexx Laboratories (IDXX) reported strong Q2 2026 earnings, beating Zacks Consensus Estimates for both earnings per share ($4.27 vs. $3.95) and revenues ($1.22 billion vs. $1.20 billion). The company has consistently surpassed analyst expectations over the past four quarters. Despite the positive results, Idexx …

IDXX main company

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

12:15 4 Aug 2026

Reuters Earnings Main company 🇺🇸 United States

Waters lifts annual forecasts on strong lab-equipment and diagnostics demand

Waters (WAT.N) has increased its annual profit and revenue forecasts after exceeding second-quarter Wall Street estimates. This positive outlook is attributed to robust demand for its laboratory equipment and better-than-expected growth from recently acquired businesses, including biosciences and diagnostics segments from Becton Dickinson. The …

WAT main company

Sharemaestro market context Trend signal active 52 weeks +36.4%

12:09 4 Aug 2026

TradingView Analyst action Main company 🇺🇸 United States

Twist Bioscience Corporation Stock 12‑Month Price Target Raised to $109.67, Implies 20% Upside

Analysts have raised the 12-month average price target for Twist Bioscience Corporation (TWST) stock to $109.67, up from $104. This new target suggests a potential 20% upside from its July 31st closing price, with individual forecasts ranging from $85 to $120 per share. The …

TWST main company

Sharemaestro market context Trend signal active 52 weeks +314.7%

12:08 4 Aug 2026

Stock Titan Deals and strategy Main company 🇺🇸 United States

Revvity deal to divest China immunodiagnostics; close expected 2027

Revvity (NYSE: RVTY) announced strong financial results for the second quarter of 2026, with adjusted EPS from continuing operations of $1.41, surpassing expectations. The company also entered a definitive agreement to divest its China Immunodiagnostics business, which represented approximately 6% of its fiscal year …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

12:08 4 Aug 2026

StockStory Earnings Main company 🇺🇸 United States

Revvity (NYSE:RVTY) Reports Upbeat Q2 CY2026

Revvity (NYSE:RVTY) reported strong Q2 CY2026 results, exceeding market expectations with a 7.2% year-on-year revenue increase to $729.7 million and non-GAAP EPS of $1.41, a 15.9% beat. The company also raised its full-year revenue and adjusted EPS guidance, indicating an encouraging outlook. Despite past …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

12:08 4 Aug 2026

Stock Titan Market update Main company 🇺🇸 United States

Labcorp Test May Identify Prostate Cancer Patients for TRUQAP

Labcorp (NYSE: LH) has announced the nationwide availability of Roche's VENTANA PTEN (SP218) RxDx Assay, the first FDA-approved immunohistochemistry companion diagnostic for prostate adenocarcinoma. This test identifies PTEN protein loss in tumors, helping to determine which patients may be eligible for combination treatment with …

LH main company

Sharemaestro market context Trend signal active 52 weeks +15.6%

12:08 4 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

IDEXX Labs earnings beat by $0.31, revenue topped estimates

IDEXX Labs (NASDAQ: IDXX) reported strong Q2 results, with EPS of $4.27 surpassing analyst estimates by $0.31 and revenue reaching $1.22 billion, exceeding the consensus. The company also provided optimistic FY 2026 guidance, projecting EPS between $14.69 and $14.94 and revenue of $4.70 billion …

IDXX main company

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

12:07 4 Aug 2026

MarketBeat Earnings Provider-linked mention 🇺🇸 United States

Royal Bank of Canada Has $38.91 Million Position in Quest Diagnostics Incorporated $DGX

Royal Bank of Canada decreased its stake in Quest Diagnostics (DGX) by 13.2% in the first quarter, holding shares valued at $38.91 million. Other institutional investors adjusted their positions, with Vanguard Group, State Street Corp, Boston Partners, Morgan Stanley, and EdgePoint Investment Group all …

DGX mentioned

Sharemaestro market context Trend signal active 52 weeks +31.8% · Next-week setup positive 58.1%

11:56 4 Aug 2026

marketscreener.com Earnings Main company 🇺🇸 United States

Earnings Flash (IDXX) IDEXX Laboratories Posts Q2 Adjusted EPS $4.07, vs. FactSet Est of $3.94

IDEXX Laboratories (IDXX) announced its Q2 adjusted earnings per share (EPS) of $4.07, surpassing the FactSet estimate of $3.94. The company also reported increased Q2 comparable earnings and revenue, and provided an updated 2026 outlook. IDEXX Laboratories is a global leader in diagnostic instruments …

IDXX main company LH mentioned

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

11:49 4 Aug 2026

marketscreener.com Earnings Main company 🇺🇸 United States

Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q2 Revenue $1.22B, vs. FactSet Est of $1.20B

IDEXX Laboratories, Inc. (IDXX) reported strong second-quarter results, with revenue reaching $1.22 billion, surpassing FactSet's estimate of $1.20 billion. The company also announced adjusted EPS of $4.07, exceeding the FactSet estimate of $3.94. This positive earnings flash highlights IDEXX's continued growth in the medical …

IDXX main company

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

11:40 4 Aug 2026

Simply Wall St Market update Main company 🇺🇸 United States

Guardant Health (GH) Filed A Shelf Registration To Keep Future Funding Options Open

Guardant Health (GH) has filed a universal shelf registration statement, granting it the flexibility to issue various securities in the future. This move enables the company to raise capital through debt, equity, or hybrid instruments, potentially supporting future financing, acquisitions, or balance sheet adjustments. …

GH main company

Sharemaestro market context Trend signal active 52 weeks +156.0%

11:39 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Waters Corporation (NYSE:WAT) Exceeds Q2 CY2026 Expectations

Waters Corporation (NYSE:WAT) announced better-than-expected Q2 CY2026 revenue of $1.65 billion, a 113% year-on-year increase, and non-GAAP profit of $3.05 per share, exceeding analyst estimates. Despite strong revenue growth and increased free cash flow margin, the company experienced a significant drop in operating margin …

WAT main company

Sharemaestro market context Trend signal active 52 weeks +36.4%

11:38 4 Aug 2026

Investing.com Earnings Main company 🇺🇸 United States

IDEXX Labs stock rises nearly 4% on earnings beat and raised guidance

IDEXX Laboratories Inc. reported strong second-quarter results, exceeding analyst expectations for both adjusted EPS and revenue. The company also raised its full-year 2026 EPS guidance, leading to a nearly 4% rise in its stock during pre-market trading. Key drivers included the "Technology for Life" …

IDXX main company

Sharemaestro market context Price below Trend Line 52 weeks -14.7%

11:37 4 Aug 2026

Investing.com Canada Guidance Main company 🇺🇸 United States

Revvity beats estimates, raises guidance as stock jumps By Investing.com

Revvity, Inc. (NYSE:RVTY) reported strong second-quarter results, surpassing analyst expectations with adjusted EPS of $1.41 and revenue of $730 million. The health science solutions provider also raised its full-year 2026 guidance, projecting revenue of $2.83-$2.86 billion and pro forma adjusted EPS of $5.30-$5.40, driven …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

11:36 4 Aug 2026

24/7 Wall St. Earnings Main company 🇺🇸 United States

Revvity (RVTY) Q2 2026 Earnings

Revvity (RVTY) reported strong Q2 2026 earnings, with EPS of $1.41 surpassing estimates by 15.9% and revenue of $730 million exceeding expectations by 3.8%. The Diagnostics segment was a key driver with 11% organic growth, offsetting a decline in Life Sciences. Management raised full-year …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

11:26 4 Aug 2026

marketscreener.com Earnings Main company 🇺🇸 United States

Earnings Flash (RVTY) Revvity, Inc. Reports Q2 Revenue $729.7M, vs. FactSet Est of $703.0M

Revvity, Inc. (RVTY) announced its Q2 revenue of $729.7 million, surpassing FactSet's estimate of $703.0 million. The company also reported Q2 adjusted EPS of $1.41 per share, exceeding the FactSet estimate of $1.21. Furthermore, Revvity expects its full-year 2026 revenue to be in the …

RVTY main company

Sharemaestro market context Trend signal active 52 weeks +24.4%

11:16 4 Aug 2026

Quiver Quantitative Earnings Main company 🇺🇸 United States

Waters Reports $1.645 Billion Revenue In Second Quarter 2026

Waters Corporation (WAT) reported second-quarter 2026 revenue of $1.645 billion, including significant contributions from recently acquired businesses, despite posting a GAAP net loss of $136 million. The company raised its full-year 2026 guidance for both reported revenue and adjusted EPS, reflecting optimistic future projections. …

WAT main company

Sharemaestro market context Trend signal active 52 weeks +36.4%

11:15 4 Aug 2026

Manufacturing Chemist Market update Main company 🇺🇸 United States

Thermo Fisher Scientific launches new general purpose centrifuges with natural refrigerant cooling

Thermo Fisher Scientific has introduced its new X2 and S2 Series Centrifuges, general purpose centrifuges designed for medical research, biopharma, and clinical labs. These new models feature natural refrigerant cooling systems, making Thermo Fisher the first to offer a complete refrigerated centrifuge portfolio using …

TMO main company

Sharemaestro market context Trend signal started 52 weeks +18.1%

11:15 4 Aug 2026

The Manila Times Market update Main company 🇺🇸 United States

Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

Biodesix, Inc. announced that its leadership team will participate in Canaccord Genuity's 46th Annual Growth Conference. They will present in a fireside chat and hold in-person investor meetings from August 11-12, 2026. The fireside chat is scheduled for August 12, 2026, at 3:30 PM …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8%

11:11 4 Aug 2026

Market source Earnings Main company 🇺🇸 United States

Twist Bioscience Corp (TWST) (Q3 2026) Earnings Call Highlights: Record Revenue and AI-Driven ...

Twist Bioscience Corp (TWST) announced record revenue of $118.4 million in Q3 2026, marking its 14th consecutive quarter of growth, with AI-enabled drug discovery orders expected to achieve triple-digit growth. The company improved its gross margin to 52.8% and expects to reach adjusted EBITDA …

TWST main company

Sharemaestro market context Trend signal active 52 weeks +314.7%

11:10 4 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Biodesix leadership's Aug. 12 fireside chat will be webcast live

Biodesix (Nasdaq: BDSX) announced that its leadership team will participate in Canaccord Genuity’s 46th Annual Growth Conference from August 11-12, 2026. The team will host a fireside chat on August 12, 2026, at 3:30 PM ET, which will be webcast live and available for …

BDSX main company

Sharemaestro market context Trend signal active 52 weeks +164.7% · Next-week setup negative 43.8%

11:00 4 Aug 2026

Stock Titan Earnings Main company 🇺🇸 United States

Waters raises 2026 forecast after adjusted earnings per share reach $3.05

Waters Corporation reported strong Q2 2026 financial results, with revenue reaching $1.645 billion and adjusted EPS of $3.05, exceeding guidance due to broad-based outperformance. The company is raising its full-year 2026 guidance across all components, anticipating organic constant currency revenue growth of 7-9% and …

WAT main company

Sharemaestro market context Trend signal active 52 weeks +36.4%

10:41 4 Aug 2026

PR Newswire Regulatory and legal Main company 🇺🇸 United States

GRAL DEADLINE TODAY: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Hagens Berman Sobol Shapiro LLP has filed a securities fraud class action lawsuit against GRAIL, Inc. (NASDAQ: GRAL), urging investors with substantial losses to join before the August 4, 2026, lead plaintiff deadline. The lawsuit alleges that GRAIL and its executives misled investors about …

GRAL main company

Sharemaestro market context Price above Trend Line 52 weeks +98.2% · Next-week setup positive 61.9%

10:39 4 Aug 2026

MarketBeat Earnings Main company 🇺🇸 United States

Segall Bryant & Hamill LLC Lowers Holdings in Qiagen N.V. $QGEN

Segall Bryant & Hamill LLC reduced its stake in Qiagen N.V. by 24.5% in the first quarter, selling 36,110 shares but still retaining 111,177 shares worth approximately $4.45 million. Despite this reduction, other institutional investors like Groupe la Francaise, Janus Henderson Group PLC, Amundi, …

QGEN main company

Sharemaestro market context Price above Trend Line 52 weeks -14.1%

10:21 4 Aug 2026

citybiz Deals and strategy Main company 🇺🇸 United States

Danaher Names Julie Sawyer Montgomery CEO as Rainer Blair Retires

Danaher Corporation has appointed Julie Sawyer Montgomery as its new President and CEO, effective October 1, 2026, succeeding Rainer Blair who is retiring. Montgomery, previously an executive vice president for Danaher's Diagnostics platform, was instrumental in significant revenue growth for the diagnostics business and …

DHR main company

Sharemaestro market context Price above Trend Line 52 weeks -3.7%